Corrections to the Perinatal Guidelines
Date
Corrections to the Perinatal Guidelines
Date: January 4, 2017
Source: Clinical Info
On January 4, 2017, the Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States were updated. Efavirenz and Table 8 Antiretroviral Drug Use in Pregnant HIV-Infected Women were updated to be consistent with the sections of the guidelines.